Skip to content
Online Vardag

Zimbabwe Rejects ‘Lopsided’ American Health Aid Agreement Over Data Fears

Health funding illustration
The proposed US financial assistance would have supported initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a significant US health deal worth 367 million US dollars (272 million pounds) over five years over the United States' demand for sensitive data.

This rejection came to light after a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa deemed the deal was "unbalanced".

A government representative has since clarified that the US was seeking genetic material for research and commercial purposes but was not willing to share the resulting advantages from any future treatments.

"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for continued negotiations to reach a deal suitable to all parties so the nation's vital HIV treatment initiative can continue.

Wider Implications

Zimbabwe's decision follows a similar case in Kenya, where a high court blocked a similar deal with the US after concerns were filed about the safety of citizens' medical information.

After returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

USAID had overseen aid for the American government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government deals to boost transparency and accountability.

Based on statements, Sixteen nations in Africa have so far signed similar agreements, representing more than $18.3bn in committed funds.

Details of the Rejected Deal

The funds for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this partnership could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through US-supported initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".

"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.

"Effectively, our country would supply the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our people should a future disease outbreak emerge."

Sovereignty and International Frameworks

He also noted that the US's withdrawal from the global health body and its push of one-on-one deals were undermining systems already established through the international organization.

The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage potential pandemics.

"This mechanism is intended to guarantee that when a country contributes its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."

These objections regarding the US deal "are not meant as hostility towards the US," he added.

"We welcome ongoing dialogue with our American counterparts on how future collaboration might be designed in a way that honours the independence and interests of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but urged that talks should continue given that a large portion of the country's Aids initiatives depended on external financing.

"If technical issues arise, such as those relating to information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," the group commented.

The halted deal highlights the complex challenges between accepting vital international aid and protecting national sovereignty in an increasingly data-driven world.

About the author

Cynthia Wallace

Digital livsstilsexpert med passion för att förenkla vardagen genom teknik och smarta rutiner.

Online Vardag

Type to search articles.